Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Hartley

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Teratogenesis, Carcinogenesis, and Mutagenesis|April 12, 2002
In vitro isoflavone supplementation reduces hydrogen peroxide-induced DNA damage in spermJ Sierens, J A Hartley, M J Campbell, et al.
Journal of Medicinal Chemistry|April 2, 1993
In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycinM Lee, A L Rhodes, M D Wyatt, et al.
British Journal of Cancer|September 13, 2007
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapyP Wynne, C Newton, J A Ledermann, et al.
Biochemical Pharmacology|November 6, 1991
N2,N4,N6-tri(hydroxymethyl)-N2,N4,N6-trimethylmelamine (trimelamol) is an efficient DNA cross-linking agent in vitroC Jackson, J A Hartley, T C Jenkins, et al.
British Journal of Cancer|February 1, 1990
DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate)M Broggini, J A Hartley, W B Mattes, et al.
Anti-Cancer Drug Design|June 1, 1994
Molecular and cellular pharmacology of novel photoactive psoralen and coumarin conjugates of pyrrole- and imidazole-containing analogues of netropsinJ A Hartley, S R McAdam, S Das, et al.
International Journal of Cancer|March 4, 1997
DNA repair capacity and cisplatin sensitivity of human testis tumour cellsB Köberle, K A Grimaldi, A Sunters, et al.
British Journal of Cancer|June 21, 2007
Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cellsC Pepper, H Lowe, C Fegan, et al.
Biochemistry|January 12, 1988
Structural and dynamic aspects of binding of a prototype lexitropsin to the decadeoxyribonucleotide d(CGCAATTGCG)2 deduced from high-resolution 1H NMR StudiesM Lee, D K Chang, J A Hartley, et al.
Anti-Cancer Drug Design|March 1, 1989
Interaction of bisantrene anti-cancer agents with DNA: footprinting, structural requirements for DNA unwinding, kinetics and mechanism of binding and correlation of structural and kinetic parameters with anti-cancer activityJ A Elliott, W D Wilson, R G Shea, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Teratogenesis, Carcinogenesis, and Mutagenesis|April 12, 2002
In vitro isoflavone supplementation reduces hydrogen peroxide-induced DNA damage in spermJ Sierens, J A Hartley, M J Campbell, et al.
Journal of Medicinal Chemistry|April 2, 1993
In vitro cytotoxicity of GC sequence directed alkylating agents related to distamycinM Lee, A L Rhodes, M D Wyatt, et al.
British Journal of Cancer|September 13, 2007
Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapyP Wynne, C Newton, J A Ledermann, et al.
Biochemical Pharmacology|November 6, 1991
N2,N4,N6-tri(hydroxymethyl)-N2,N4,N6-trimethylmelamine (trimelamol) is an efficient DNA cross-linking agent in vitroC Jackson, J A Hartley, T C Jenkins, et al.
British Journal of Cancer|February 1, 1990
DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate)M Broggini, J A Hartley, W B Mattes, et al.
Anti-Cancer Drug Design|June 1, 1994
Molecular and cellular pharmacology of novel photoactive psoralen and coumarin conjugates of pyrrole- and imidazole-containing analogues of netropsinJ A Hartley, S R McAdam, S Das, et al.
International Journal of Cancer|March 4, 1997
DNA repair capacity and cisplatin sensitivity of human testis tumour cellsB Köberle, K A Grimaldi, A Sunters, et al.
British Journal of Cancer|June 21, 2007
Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cellsC Pepper, H Lowe, C Fegan, et al.
Biochemistry|January 12, 1988
Structural and dynamic aspects of binding of a prototype lexitropsin to the decadeoxyribonucleotide d(CGCAATTGCG)2 deduced from high-resolution 1H NMR StudiesM Lee, D K Chang, J A Hartley, et al.
Anti-Cancer Drug Design|March 1, 1989
Interaction of bisantrene anti-cancer agents with DNA: footprinting, structural requirements for DNA unwinding, kinetics and mechanism of binding and correlation of structural and kinetic parameters with anti-cancer activityJ A Elliott, W D Wilson, R G Shea, et al.
Pageof 12